๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

89Sr Therapy: Strontium plasma clearance in disseminated prostatic carcinoma

โœ Scribed by Glen M. Blake; John F. Wood; Peter J. Wood; Maureen A. Zivanovic; Valerie J. Lewington


Publisher
Springer
Year
1989
Tongue
English
Weight
542 KB
Volume
15
Category
Article
ISSN
0340-6997

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Sr-89 therapy: Strontium kinetics in dis
โœ G. M. Blake; M. A. Zivanovic; A. J. McEwan; D. M. Ackery ๐Ÿ“‚ Article ๐Ÿ“… 1986 ๐Ÿ› Springer ๐ŸŒ English โš– 824 KB

Strontium kinetics were investigated in a group of 14 patients receiving 89Sr palliation for metastatic bone disease secondary to prostatic carcinoma. Using 85Sr as a tracer, total body strontium retention R(t) was monitored for a 3 month period following 89Sr administration, and at 90 days was foun

Measurements of the strontium plasma cle
โœ Glen M. Blake; Maureen A. Zivanovic; Valerie J. Lewington ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› Springer ๐ŸŒ English โš– 373 KB

The total strontium plasma clearance rate due to excretion through the kidneys and gut has an important influence on the absorbed does delivered to skeletal metastases and red bone marrow in patients receiving 89Sr radionuclide therapy for disseminated prostatic carcinoma. Although a measurement of

89Sr radionuclide therapy: Dosimetry and
โœ G. M. Blake; M. A. Zivanovic; A. J. McEwan; V. B. Batty; D. M. Ackery ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› Springer ๐ŸŒ English โš– 570 KB

We present dosimetry for spinal metastases and red bone marrow in two patients who received 89Sr therapy for disseminated prostatic carcinoma. Absorbed dose to metastases was estimated by combining 85Sr gamma camera studies with computed tomographic measurements of bone mass, and doses of 20 cGy/MBq